Growing EPD Business Supports ABT Stock Amid Macroeconomic Issues

Abbott’s (ABT) diversified business portfolio is well-positioned to drive continued momentum in 2024. Yet, the business environment continues to remain challenging globally. The stock carries a Zacks Rank #3 (Hold).Factors Driving ABT SharesWithin Abbott’s Established Pharmaceuticals Division (EPD) business, the company is also strategically progressing with its advancement in biosimilars. Abbott, leveraging on its leading presence in emerging markets, is enjoying a unique opportunity to scale a licensing m ...